Newest studies
Every summary in our library, newest first, as a dated timeline.
Showing 251–275 of 27,380 studies, newest first · page 11 of 1096.
October 2026 25
-
2026-10-07
A First-in-Class, Brain-Penetrant Small Molecule Inhibitor of the NOS1AP-Tau Interaction Rescues Tau Pathology In Vivo and Improves Cognition
16/100 ⚠ Preprint — not yet peer-reviewed Biomarkers bioRxiv
Key finding: A drug-resistant NOS1AP Y16A/F42A variant that retained tau binding but exhibited a 78-fold reduction in CAPTOR-1 affinity provides genetic evidence supporting an on-target mechanism. +4 more findings
Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.
Full summary, score breakdown and related studies → Original source
-
2026-10-06
A Pipeline for ADNI Resting-State Functional MRI Processing and Quality Control
16/100 ⚠ Preprint — not yet peer-reviewed Long-term cohort studies Research Square
Key finding: Processed imaging sessions are matched to temporally aligned clinical assessments to produce an analysis-ready dataset. +4 more findings
Scored 35 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.
Full summary, score breakdown and related studies → Original source
-
2026-10-06
Cognitive and Renal Outcomes of Finerenone in Older Adults With Heart Failure With Preserved Ejection Fraction: A Real-World Cohort Study
16/100 ⚠ Preprint — not yet peer-reviewed How common it is Research Square
Key finding: In older adults with HFpEF, finerenone conferred renal benefit without a detectable short-term cognitive signal. +2 more findings
Scored 50 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.
Full summary, score breakdown and related studies → Original source
-
2026-10-06
Multilingualism and ageing: Cognitive and affective trajectories in the Australian Longitudinal Study of Ageing
16/100 ⚠ Preprint — not yet peer-reviewed Mild cognitive impairment Research Square
Key finding: This study aimed to address these limitations by examining whether multilingual experience is associated with longitudinal ageing trajectories across objective and subjective measures spanning cognitive, affective, linguistic, and non-linguistic domains. +4 more findings
Scored 39 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.
Full summary, score breakdown and related studies → Original source
-
2026-10-06
Evaluating Large Language Model Diagnostic Classification in Neuropsychology
16/100 ⚠ Preprint — not yet peer-reviewed Digital health tools PsyArXiv
Key finding: Model-inferred and reference diagnoses showed exact agreement rates from 18.8% to 56.2% with poor to slight chance-corrected agreement (Cohen’s κ = −.178 to .196). +4 more findings
Scored 24 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.
Full summary, score breakdown and related studies → Original source
-
2026-10-06
Contribution of cerebrovascular lesions to neurodegeneration and cognitive decline
16/100 ⚠ Preprint — not yet peer-reviewed Vascular contributions medRxiv
Key finding: Vascular risk factors were associated with CSVD burden and progression, and WMH and PVS progression were further associated with cortical atrophy and cognitive decline, underscoring the interconnected contributions of vascular risk, CSVD, and neurodegeneration to cognitive aging and dementia risk. +4 more findings
Scored 39 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.
Full summary, score breakdown and related studies → Original source
-
2026-10-06
The protective effect of NGF mutant CHF6467 in SH SY5Y cells exposed to Aβ(1–42): a pharmacometabolomic approach
16/100 ⚠ Preprint — not yet peer-reviewed Vascular contributions bioRxiv
Key finding: Research shows NGF’s neuroprotective and regenerative effects on cholinergic neurons, with positive results in AD models and clinical studies. +2 more findings
Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.
Full summary, score breakdown and related studies → Original source
-
2026-10-06
The microbial soy metabolite S-equol mitigates cadmium neurotoxicity in mice
16/100 ⚠ Preprint — not yet peer-reviewed Disease mechanisms bioRxiv
Key finding: Cadmium is a pervasive toxic metal encountered through diet and tobacco smoke that has been associated with cognitive impairment and Alzheimer’s disease mortality, yet strategies to mitigate its neurotoxicity remain limited.
Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.
Full summary, score breakdown and related studies → Original source
-
2026-10-06
Brief Communication: Frailty and Neurocognitive Impairment in Older People Living with HIV: A Cross-Sectional Study from Southeastern Brazil
16/100 ⚠ Preprint — not yet peer-reviewed Risk factors Research Square
Key finding: Mean age was 59.6 years, and 57.8% were male. +3 more findings
Scored 31 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.
Full summary, score breakdown and related studies → Original source
-
2026-10-06
What Do Care Staff Know About Behavioural and Psychological Symptoms of Dementia? A Mixed- Methods Study in Long-Term Care
16/100 ⚠ Preprint — not yet peer-reviewed Risk factors Research Square
Key finding: Mean scores were 23.45/30 (78.2%) for general Alzheimer’s disease knowledge and 13.75/18 (76.4%) for BPSD knowledge; the scores were moderately correlated (ρ = .598, p < .001). +2 more findings
Scored 39 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.
Full summary, score breakdown and related studies → Original source
-
2026-10-06
Memory and executive functioning show differential associations with scam susceptibility in middle to older adulthood
16/100 ⚠ Preprint — not yet peer-reviewed Risk factors medRxiv
Key finding: Prior work has demonstrated a link between cognitive impairment and financial vulnerability. +4 more findings
Scored 24 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.
Full summary, score breakdown and related studies → Original source
-
2026-10-06
Circular Data Analysis for Spatial Omics
16/100 ⚠ Preprint — not yet peer-reviewed Risk factors bioRxiv
Key finding: We conclude with practical recommendations and directions for future methodological development.
Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.
Full summary, score breakdown and related studies → Original source
-
2026-10-06
Simulating the Effects of Gamma Oscillation Treatment on Selective Neurotransmitters Using The Virtual Brain and Complex Pathway Simulator
16/100 ⚠ Preprint — not yet peer-reviewed Treatments Research Square
Key finding: Alzheimer's Disease (AD), the most common neurodegenerative disease in the world, is caused by a variety of factors that lead to neuronal injury and an alteration in neurotransmitter production and release. +1 more finding
Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.
Full summary, score breakdown and related studies → Original source
-
2026-10-06
When Is Amyloid Really Cleared? Substantial Discordance Between Centiloid Quantitation and Visual Reads of Amyloid PET after Amyloid-Targeting Therapy
16/100 ⚠ Preprint — not yet peer-reviewed Brain scans and imaging medRxiv
Key finding: : Treated patients were 74±7 years old; 57% were female, 59% were apolipoprotein E ε4 carriers, and 78% had mild cognitive impairment (22% mild dementia). +4 more findings
Scored 27 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.
Full summary, score breakdown and related studies → Original source
-
2026-10-06
Person-centred care in the early post-diagnostic phase of young-onset dementia: co-created insights from service users and professionals through participatory action research
16/100 ⚠ Preprint — not yet peer-reviewed Risk genes beyond APOE Research Square
Key finding: Realising PCC in YOD requires not only identifying individual needs and appropriate care components, but also ongoing alignment of changing needs, expectations, timing, and responsibilities across the care trajectory. +1 more finding
Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.
Full summary, score breakdown and related studies → Original source
-
2026-10-06
Closed-head injury produces a delayed, region-specific defect in glucose-carbon routing at the pyruvate branchpoint in APP/PS1 KI mice
16/100 ⚠ Preprint — not yet peer-reviewed Risk genes beyond APOE bioRxiv
Key finding: Traumatic brain injury (TBI) is a risk factor for Alzheimer’s disease (AD), and both conditions are associated with impaired glucose metabolism and mitochondrial dysfunction. +1 more finding
Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.
Full summary, score breakdown and related studies → Original source
-
2026-10-06
Cross-Dataset Reanalysis of Mouse Alzheimer Disease Single-Cell RNA-Sequencing Data Reveals a Reproducible Innate Immune Activation Signature
16/100 ⚠ Preprint — not yet peer-reviewed TREM2 and immune genetics bioRxiv
Key finding: Pseudobulk differential expression, performed on 32 samples (16 AD, 16 Control) from five of the six datasets, identified 301 significant genes (FDR-adjusted p < 0.05) out of 20,629 tested, of which 290 (96.3%) were upregulated and 11 (3.7%) downregulated in AD. +2 more findings
Scored 24 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.
Full summary, score breakdown and related studies → Original source
-
2026-10-06
Sex differences in genetic liability to modifiable Alzheimer’s disease risk factors
16/100 ⚠ Preprint — not yet peer-reviewed Biomarkers medRxiv
Key finding: Educational attainment and physical activity PRSs were associated with AD in both sexes. +4 more findings
Scored 58 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.
Full summary, score breakdown and related studies → Original source
-
2026-10-06
Blood Biomarkers of Alzheimer’s Disease Neuropathology, Cognition, and Response to a Multidomain Lifestyle Intervention: Secondary analysis of the FINGER Randomized Controlled Dementia Risk Reduction Trial
16/100 ⚠ Preprint — not yet peer-reviewed Biomarkers medRxiv
Key finding: Here, we analyzed core AD plasma biomarkers (Aβ, p-tau181, p-tau217, p-tau231, NFL, GFAP) in the two-year FINGER randomized controlled multidomain lifestyle trial, which demonstrated cognitive efficacy in an at-risk older general population (N=1260). +4 more findings
Scored 44 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.
Full summary, score breakdown and related studies → Original source
-
2026-10-05
Explainable machine learning identifies predictors for postural instability and cognitive impairment in early Parkinson’s Disease
16/100 ⚠ Preprint — not yet peer-reviewed Mild cognitive impairment medRxiv
Key finding: We found comparable predictive performances of EBM models using a minimal clinico-demographic dataset compared to an extended multimodal dataset including volumetric brain imaging and fluid biomarkers.
Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.
Full summary, score breakdown and related studies → Original source
-
2026-10-05
Imputation-Based Harmonization Mitigates Site Effects Without Data Leakage in Machine Learning Studies
16/100 ⚠ Preprint — not yet peer-reviewed Digital health tools bioRxiv
Key finding: Neuroimaging studies that pool data across clinical sites often suffer from site effects — variability in imaging measures that arises from technical heterogeneity across sites as opposed to true biological signal. +4 more findings
Scored 35 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.
Full summary, score breakdown and related studies → Original source
-
2026-10-05
Plasma eMTBR-tau as a robust biomarker for Alzheimer’s disease tangle pathology up to 10 years before death
16/100 ⚠ Preprint — not yet peer-reviewed Brain tissue and pathology medRxiv
Key finding: Here, we show that a blood-based immunoassay for an endogenously-cleaved “eMTBR-tau” fragment of tau protein is strongly associated with autopsy-diagnosed Alzheimer neuropathologic change (ADNC) and predominantly reflects the burden and anatomical progression of tangle pathology but not amyloid plaque load despite being most elevated in amyloid-positive symptomatic individuals. +3 more findings
Scored 29 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.
Full summary, score breakdown and related studies → Original source
-
2026-10-05
Multi-Target Neuroprotection by Syzygium aromaticum Ethyl Acetate Fraction Against Mercuric Chloride-Induced Hippocampal Toxicity: Insights from Network Pharmacology, Molecular Docking, and In Vivo Evaluation
45/100 ✓ Peer-reviewed Vascular contributions F1000Res
Key finding: Network pharmacology integrating SwissTargetPrediction, TargetNet, GeneCards, and the Therapeutic Target Database revealed 16 overlapping dementia-associated targets, with NFKB1 emerging alongside other genes as the principal hub governing nuclear receptor signalling, oxidative stress, and neuroinflammation pathways.
Full summary, score breakdown and related studies → Original source
-
2026-10-05
Magnetic Field–Enhanced Docosahexaenoic Acid Delivery for Acetylcholine Restoration in Alzheimer’s Disease: an In Silico Study
16/100 ⚠ Preprint — not yet peer-reviewed Prevention and risk bioRxiv
Key finding: Co-evolution analysis reveals the mechanism: by the end of a 2.0 s window the field elevates DHA 7.39-fold relative to baseline, driving ACh to 133.7% of threshold versus only 18.1% without the field. +1 more finding
Scored 24 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.
Full summary, score breakdown and related studies → Original source
-
2026-10-05
Adaptive Memory and Metacognition in Older Adulthood: A Path Towards Successful Aging
16/100 ⚠ Preprint — not yet peer-reviewed Risk factors PsyArXiv
Key finding: Overall, leveraging older adults’ metacognitive abilities and enhanced motivation through targeted interventions may offer a promising approach to promoting successful aging among an increasingly growing aging population.
Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.
Full summary, score breakdown and related studies → Original source
Browse the library by subject, with the full score breakdown →